Tauhid Ali
Algemeen Directeur bij Oak Hill Bio Corp.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Josh Distler | M | 48 |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | - |
| Christian Angermayer | M | 45 |
Cambrian BioPharma, Inc.
 Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | 5 jaar |
| James Peyer | M | 37 |
Cambrian BioPharma, Inc.
Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | 5 jaar |
| Mark McHale | M | 59 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 jaar |
| Juliette Han | M | - |
Cambrian BioPharma, Inc.
Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | 4 jaar |
| Brenton Saunders | M | 56 |
Cambrian BioPharma, Inc.
Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | - |
| Steve Jurvetson | M | 57 |
Cambrian BioPharma, Inc.
Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | - |
| Edwin Moses | M | 69 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 jaar |
| Ramon Chavez Márquez | M | 60 |
Cambrian BioPharma, Inc.
Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | 4 jaar |
| Ramy Farid | M | 59 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 jaar |
| Paul Farr | M | - |
Cambrian BioPharma, Inc.
Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | - |
| David Colpman | M | 62 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 jaar |
| Daniel Curran | M | 57 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 jaar |
| Marie Yurkovich | M | - |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | - |
| Maryanna Saenko | F | - |
Cambrian BioPharma, Inc.
Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | - |
| Victoria Niklas | M | 64 |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 8 | 50.00% |
| Verenigd Koninkrijk | 8 | 50.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Tauhid Ali
- Persoonlijk netwerk
